Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward J Gane

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
Journal of Gastroenterology and Hepatology|May 11, 2007
Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosisSachin Mathur, Edward J Gane, John L McCall, et al.
The New Zealand Medical Journal|July 6, 2014
The impact of oral antiviral therapy on long-term survival of hepatitis B surface antigen-positive patients on haemodialysisMaggie M G Ow, Janak R de Zoysa, Edward J Gane
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2017
Reply to Ozaras et alMark S Sulkowski, Diana M Brainard, Jenny C Yang, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2025
Letters on "Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment." Authors' ReplyGrace Lai-Hung Wong, Edward J Gane, Wan-Long Chuang, et al.
Journal of Gastroenterology and Hepatology|September 25, 2014
Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patientsJohn C Hsiang, Edward J Gane, Wayne W Bai, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 31, 2007
Hypermetabolism predicts reduced transplant-free survival independent of MELD and Child-Pugh scores in liver cirrhosisSachin Mathur, Szelin Peng, Edward J Gane, et al.
Metabolism: Clinical and Experimental|May 8, 2012
Oral β-blockade in relation to energy expenditure in clinically stable patients with liver cirrhosis: a double-blind randomized cross-over trialWai Gin Lee, John L McCall, Edward J Gane, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidatesEdward J Gane, Scott Patterson, Simone I Strasser, et al.
Hepatology International|July 1, 2011
The effect of changes of model for end-stage liver disease score during waiting time on post-liver transplant mortalityMohammad A B Al-Freah, Edward J Gane, Vicki Livingstone, et al.
The American Journal of Clinical Nutrition|May 11, 2007
Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive studySzelin Peng, Lindsay D Plank, John L McCall, et al.
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Journal of Gastroenterology and Hepatology|May 11, 2007
Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosisSachin Mathur, Edward J Gane, John L McCall, et al.
The New Zealand Medical Journal|July 6, 2014
The impact of oral antiviral therapy on long-term survival of hepatitis B surface antigen-positive patients on haemodialysisMaggie M G Ow, Janak R de Zoysa, Edward J Gane
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2017
Reply to Ozaras et alMark S Sulkowski, Diana M Brainard, Jenny C Yang, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2025
Letters on "Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment." Authors' ReplyGrace Lai-Hung Wong, Edward J Gane, Wan-Long Chuang, et al.
Journal of Gastroenterology and Hepatology|September 25, 2014
Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patientsJohn C Hsiang, Edward J Gane, Wayne W Bai, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 31, 2007
Hypermetabolism predicts reduced transplant-free survival independent of MELD and Child-Pugh scores in liver cirrhosisSachin Mathur, Szelin Peng, Edward J Gane, et al.
Metabolism: Clinical and Experimental|May 8, 2012
Oral β-blockade in relation to energy expenditure in clinically stable patients with liver cirrhosis: a double-blind randomized cross-over trialWai Gin Lee, John L McCall, Edward J Gane, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidatesEdward J Gane, Scott Patterson, Simone I Strasser, et al.
Hepatology International|July 1, 2011
The effect of changes of model for end-stage liver disease score during waiting time on post-liver transplant mortalityMohammad A B Al-Freah, Edward J Gane, Vicki Livingstone, et al.
The American Journal of Clinical Nutrition|May 11, 2007
Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive studySzelin Peng, Lindsay D Plank, John L McCall, et al.
Pageof 13